Curated News
By: NewsRamp Editorial Staff
August 19, 2026
LataMed AI's Mobile App Nears Launch for Latin America
TLDR
- LataMed AI (OTC: LMED) advances mobile app to launch, positioning for early lead in Latin America's digital health market.
- LataMed AI finalizes testing, optimization, and deployment prep for its mobile app, expecting Apple and Google store submission within weeks.
- LataMed AI's mobile app aims to improve healthcare access in Latin America, where smartphones are key, fostering a more connected ecosystem.
- LataMed AI's app, launching soon, will integrate AI tools like CardioAI and PulmoAI, offering scalable mobile health services.
Impact - Why it Matters
This news matters because it signals LataMed AI's move from development to deployment, potentially expanding access to digital healthcare services in Latin America. The mobile app could bridge gaps in healthcare access by providing a user-friendly platform for patients and providers, leveraging AI tools like CardioAI, PulmoAI, and NeuroAI. If successful, it could enhance healthcare connectivity and efficiency in a region where smartphone usage is high, aligning with broader trends toward telemedicine and digital health.
Summary
LataMed AI Corp. (OTC: LMED), a healthcare technology company focused on digital health infrastructure and AI-supported medical solutions for Latin America, has announced that its mobile healthcare application has entered the final development stage. The company is currently completing testing, optimization, and deployment preparation, with plans to submit the app for distribution via the Apple App Store and Google Play in the coming weeks. This milestone marks a transition from development to public availability, providing users with a convenient mobile access point to the LataMed AI digital healthcare ecosystem.
The application is designed to offer a scalable foundation for future healthcare-related functionalities, including patient-facing tools, provider interaction, digital communications, access to medical information, and healthcare-service coordination. Dr. Kevin Rodan Levy, CEO, emphasized the importance of mobile accessibility in Latin America, where smartphones are a primary means of accessing digital services. The app aims to connect patients, healthcare professionals, pharmacies, insurers, and other stakeholders within an integrated digital healthcare environment. The company also continues to develop AI-supported technologies like CardioAI, PulmoAI, and NeuroAI, which may be integrated into the mobile platform subject to regulatory approval.
LataMed AI believes this release is a significant step toward making its technology accessible to users and expanding its digital healthcare infrastructure. The company will provide updates on submission and availability as milestones are completed. For more information, visit https://latamed.ai or review SEC filings at www.sec.gov.
Source Statement
This curated news summary relied on content distributed by NewMediaWire. Read the original source here, LataMed AI's Mobile App Nears Launch for Latin America
